Last Transaction | Last Three Months | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
SEC Filing | Transaction | Insider | Sentiment | Company | Holdings Change | Buy Amount | Sell Amount | Buy Price Range | Sell Price Range | |
04-Jan-24 5:07 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 100% 0 to 178.0K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:06 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 71% 250.01K to 428.01K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:04 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 322% 55.25K to 233.25K | 0 | 0 | -- | -- | Show Txns | ||
26-Mar-24 4:32 PM View: | 26-Mar-24 Option Exercise $2.88M | Cartesian Therapeutics, Inc. - RNAC | 9% 37.25M to 40.6M | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:05 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 84% 212.88K to 390.88K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:07 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 1777% 261.96K to 4.92M | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:05 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 2543% 7.0K to 185.0K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:08 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 100% 0 to 2.42M | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:06 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 100% 0 to 548.2K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:04 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 5% 3.56M to 3.74M | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:12 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 40% 447.39K to 625.39K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:08 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 100% 0 to 778.2K | 0 | 0 | -- | -- | Show Txns | ||
04-Jan-24 5:03 PM View: | 02-Jan-24 Grant 0 | Cartesian Therapeutics, Inc. - RNAC | 100% 0 to 1.53M | 0 | 0 | -- | -- | Show Txns |